We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




German Red Cross and Cerus Develop Erythrocyte System

By LabMedica International staff writers
Posted on 06 Oct 2008
The German Red Cross in the Baden-Württemberg and Hesse regions (DRK; Frankfurt, Germany) agreed to collaborate with Cerus Corp. More...
(Concord, CA, USA) in the development of the company's Intercept blood system for red blood cells. DRK Frankfurt will invest both expertise and personnel for the commercial system design, commercial system validation, and activities directed toward German regulatory approval. In return, DRK Frankfurt will receive royalties on future sales of the Intercept red blood cell system in Europe.

The collaboration provides Cerus with direct access to DRK Frankfurt's scientific and operational expertise in relevant areas. The contract commits resources from the DRK Frankfurt to support the development of the commercial product and design of a system compatible with blood processing procedures in Europe. Under the agreement, the two organizations will also work together on planning for phase III and phase IV clinical trials of the red blood cell system in Europe.

Cerus Corp. is a biomedical products company focused on commercializing the Intercept blood system to enhance blood safety. The system is designed to inactivate blood-borne pathogens in donated blood components intended for transfusion. Cerus currently markets the Intercept blood system for both platelets and plasma in Europe and the Middle East. The Intercept red blood cell system is currently in clinical development.

The DRK Frankfurt actively collaborates with transfusion medicine professionals within Germany and worldwide, sharing with them data on best practices in blood banking. The DRK Frankfurt collects and processes 1.2 million units of red blood cells annually and has a team that has conducted translational research in transfusion medicine for many years.

Related Links:
German Red Cross
Cerus


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Serum Indices Control
Acusera Serum Indices Control
New
Slide Scanner System
NanoZoomer S540MD
Gold Member
Platelet Function Analyzer
PL-12
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers from the Department of Chemistry at Aarhus University have developed and tested a new technology that can identify and measure the concentration of pharmaceuticals in under 10 minutes. Today, this process takes up to an hour. That is critical waiting time for patients suffering from a stroke. (Image Credit: Aarhus University)

Point-of-Care Blood Test Could Speed Treatment Decisions in Acute Stroke

Minutes can shape treatment decisions in emergency stroke care, particularly when physicians need to know whether a patient is taking anticoagulants before administering clot-dissolving therapy.... Read more

Microbiology

view channel
Image: The clearance also broadens QIAstat-Dx\'s infectious disease testing menu in the U.S., which already includes panels for respiratory and gastrointestinal infections, as well as meningitis and encephalitis (Photo courtesy of Qiagen)

One-Hour Molecular Panel Expands Bloodstream Infection Testing for Gram-Negative Pathogens

Bloodstream infections can progress rapidly and lead to sepsis, organ failure, and death. In the United States, about 1.7 million adults develop sepsis each year, and at least 350,000 die during hospitalization... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.